Skip to main content
. Author manuscript; available in PMC: 2019 Jan 13.
Published in final edited form as: J Alzheimers Dis. 2018;66(3):1213–1221. doi: 10.3233/JAD-180564

Fig. 1.

Fig. 1.

Kaplan-Meier survival curves examining relationships between depression, antidepressant use and preclinical Alzheimer disease (AD) as reflected by positivity on any of the four biomarkers: (A) depression and antidepressant use; (B) antidepressant use and preclinical AD; (C) depression and preclinical AD.